4//SEC Filing
Beaupre Darrin 4
Accession 0001610717-25-000043
CIK 0001676725other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:03 PM ET
Size
5.5 KB
Accession
0001610717-25-000043
Insider Transaction Report
Form 4
Beaupre Darrin
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-27+185,000→ 185,000 totalExercise: $20.24Exp: 2035-02-26→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
Related Parties
1- filerCIK 0001581198
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:03 PM ET
- Size
- 5.5 KB